Information Provided By:
Fly News Breaks for March 8, 2018
TGTX
Mar 8, 2018 | 12:00 EDT
H.C. Wainwright analyst Edward White raised his price target for TG Therapeutics to $38 following the company's Q4 results. The analyst believes TG has a cash runway "well into" 2019 and he keeps a Buy rating on the shares.
News For TGTX From the Last 2 Days
There are no results for your query TGTX